Vincent Tutino, Ph.D., CEO
Dr. Tutino is a research assistant professor in the Neurosurgery and Biomedical Engineering Departments at the State University of New York at Buffalo. He has extensive training and translational research in neurovascular disease, genetics, and biochemistry. His background in neurovascular biology and specialization in clinical intracranial aneurysm research helped him conceptualize the diagnostic screening tool needed to identify unruptured intracranial aneurysms in patients.
Hui Meng, Ph.D., CSO
Dr. Meng is a professor of Mechanical & Aerospace Engineering, Biomedical Engineering, and Neurosurgery at the State University of New York at Buffalo. Her diverse background and interdisciplinary training has given her the opportunity to lead several multidisciplinary research projects incorporating engineering, computation, biology, and medicine. In addition to her academic appointments at the University at Buffalo, she is the co-director of the Toshiba Stroke and Vascular Research Center in Buffalo, NY which has given her a extensive experience studying neurovascular diseases and intracranial aneurysms.
Jeffrey Harvey, M.S., CFO
Mr. Harvey earned an M.S. in nuclear engineering from the Massachusetts Institute of Technology and brings decades of investment experience to the team. As an experienced entrepreneur, he has helped secure funding for various public and private start-up ventures, including a Buffalo-based company developing treatment for Duchene muscular dystrophy. Since the passing of his wife from the rupture of a brain aneurysm 15 years ago, he has been actively involved in the Brain Aneurysm Foundation and an advocate for early detection of intracranial aneurysms.
Kenneth Snyder, M.D., Ph.D., CMO
Dr. Snyder trained as a physician-scientist at the State University of New York where he earned a Ph.D. in physiology and biophysics. He currently is an assistant professor of neurosurgery, radiology, and neurology at the University at Buffalo and is an attending neurosurgeon with the University at Buffalo Neurosurgery group. In addition to performing frequent endovascular interventions and open-skull intracranial aneurysm surgeries at the Gates Vascular Institute in Buffalo, NY, he has experience with large national clinical research trials.
Kerry Poppenberg , Ph.D., Clinical Data Scientist
Dr. Poppenberg earned a Ph.D. in Biomedical Engineering from the State University of New York at Buffalo in February 2020 with a focus on blood-based biomarkers and epigenetic mechanisms of intracranial aneurysms. She has extensive experience with all stages of clinical research, from patient recruitment to data analysis. She brings a diverse set of skills, encompassing vascular disease pathogenesis, bioinformatics, computational data analysis, and machine learning, to the team.
Hamidreza Rajabzadeh-Oghaz, Ph.D., Clinical Data Scientist
Dr. Rajabzadeh-Oghaz received his PhD in Mechanical Engineering from the State University of New York at Buffalo. He is a specialist in image-based computational analysis and building statistical models for rupture risk assessment of intracranial aneurysms. At Neurovascular Diagnostics he is working to merge its blood-based biomarkers with image-based computational models to improve risk assessment and management of intracranial aneurysms.
OUR PARTNERS
